Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Artif Organs ; 44(4): 394-401, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31693189

ABSTRACT

Cardiopulmonary bypass (CPB) is often necessary for congenital cardiac surgery, but CPB can alter drug pharmacokinetic parameters resulting in underdosing. Inadequate plasma levels of antibiotics could lead to postoperative infections with increased morbidity. The influence of pediatric CPB systems on cefazolin and clindamycin plasma levels is not known. We have measured plasma levels of cefazolin and clindamycin in in vitro pediatric CPB systems. We have tested three types of CPB systems. All systems were primed and spiked with clindamycin and cefazolin. Samples were taken at different time points to measure the recovery of cefazolin and clindamycin. Linear mixed model analyses were performed to assess if drug recovery was different between the type of CPB system and sampling time point. The experiments were conducted at a tertiary university hospital. 81 samples were analyzed. There was a significant difference in the recovery over time between CPB systems for cefazolin and clindamycin (P < .001). Cefazolin recovery after 180 minutes was 106% (95% CI: 91-123) for neonatal, 99% (95% CI: 85-115) for infant, and 77% (95% CI: 67-89) for pediatric systems. Clindamycin recovery after 180 minutes was 143% (95% CI: 116-177) for neonatal, 111% (95% CI: 89-137) for infant, and 120% (95% CI: 97-149) for pediatric systems. Clindamycin recovery after 180 minutes compared to the theoretical concentration was 0.4% for neonatal, 1.2% for infants, and 0.6% for pediatric systems. The recovery of cefazolin was high in the neonatal and infant CPB systems and moderate in the pediatric system. We found a large discrepancy between the theoretical and measured concentrations of clindamycin in all tested CPB systems.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Cardiopulmonary Bypass , Cefazolin/pharmacokinetics , Clindamycin/pharmacokinetics , Heart Defects, Congenital/surgery , Humans , Pediatrics/instrumentation
2.
J Craniomaxillofac Surg ; 36(8): 468-72, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18783957

ABSTRACT

OBJECTIVES: It is unclear to what extent pharmacokinetic data from bone outside the facial area can be transferred to the maxillofacial area. The aim of this study was to evaluate the penetration characteristics of piperacillin-tazobactam into human jaw and hip bone as a model for different bone characteristics. MATERIALS AND METHODS: The drug was administered at the start of surgery in a single 15-min intravenous infusion dose (4g piperacillin & 0.5g tazobactam i.v.). Plasma and bone samples of ten patients were analyzed. RESULTS: Mean concentration of piperacillin in plasma was 309microg/ml at 0.5h declining at 4h to 14microg/ml. The respective values for tazobactam were 34microg/ml declining to 2.8microg/ml. The piperacillin-tazobactam ratio dropped during the study interval from 0.5h: 9.2%+/-0.8 to 2h: 7.2%+/-1.1 and 4h: 4.9%+/-0.7. Mean bone concentrations of piperacillin and tazobactam were 9.0+/-11.6microg/g and 1.2+/-1.3microg/g, respectively. Mean penetration ratios for all bone samples were 15% (+/-17) for piperacillin and 13% (+/-14) for tazobactam without a difference between bone of different origin. DISCUSSION: Piperacillin-tazobactam levels in jaw bone tissue after a single dose are sufficient to assure antibacterial activity of the combination and are above the minimal inhibitory concentrations of the most relevant pathogens in head and neck surgery. Our data suggests the use of piperacillin-tazobactam as an alternative for the therapy of severe infections of the head and neck.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Jaw/drug effects , Pelvic Bones/drug effects , beta-Lactamases/pharmacokinetics , Adolescent , Adult , Anti-Bacterial Agents/blood , Drug Combinations , Female , Humans , Male , Middle Aged , Penicillanic Acid/analogs & derivatives , Penicillanic Acid/blood , Penicillanic Acid/pharmacokinetics , Piperacillin/blood , Piperacillin/pharmacokinetics , Piperacillin, Tazobactam Drug Combination , Tissue Distribution , Young Adult , beta-Lactamase Inhibitors , beta-Lactamases/blood
3.
Exp Eye Res ; 80(3): 425-34, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15721624

ABSTRACT

The purpose of this study was to determine the shear compliance of human crystalline lenses as a function of age and frequency. Dynamic mechanical analysis was performed on 39 human lenses, ranging in age from 18 to 90 years, within the frequency range of 0.001-30 Hz. The lenses were stored at -70 degrees C before being measured. The influence of freezing on the mechanical properties was determined using pairs of porcine lenses, with one lens measured directly after enucleation and the other after freezing. The measurement method had a repeatability standard deviation of 4 and 6% for the storage and loss compliance, respectively. The reproducibility standard deviation was 31 and 33% for the storage and loss compliance respectively. On average, freezing increased the storage compliance by 8% and increased the loss compliance by 32%, both depending slightly on age and frequency. The human lenses exhibited a distinct viscoelastic behavior. The storage and loss compliance depended strongly on age and decreased a factor 1000 over a lifetime. Dynamic mechanical analysis has proven to be a successful technique for characterizing the mechanical properties of the human crystalline lens. The shear compliance decreases exponentially with age.


Subject(s)
Aging/physiology , Lens, Crystalline/physiology , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Biomechanical Phenomena , Elasticity , Freezing , Humans , Middle Aged , Reproducibility of Results , Stress, Mechanical , Swine , Viscosity
SELECTION OF CITATIONS
SEARCH DETAIL
...